首页> 外文期刊>Histology and histopathology >Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
【24h】

Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.

机译:人类白细胞抗原-G(HLA-G)作为人类恶性肿瘤的诊断,预后和肿瘤免疫逃逸的标记物。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human leukocyte antigen-G (HLA-G) is a non-classical HLA-class Ib molecule with multiple immunoregulatory properties. Its main functions in physiological conditions are to abolish maternal immune cell activity against fetus and to establish immune tolerance at the maternal-fetal interface. In oncology, HLA-G molecules are aberrantly expressed in a variety of human neoplastic diseases and play an important role in the escape of tumor cells from immune surveillance. In the past few years, making use of HLA-G protein expression in tissues and circulating levels in body fluids as a tumor marker have been the focus of extensive research in the diagnosis and prognosis of several human malignancies. In addition, this molecule might be a promising target for future immune therapeutic approaches based on its immune tolerant functions and its highly specific expression for malignant transformation. In this review, we will summarize available literature data as well as our own works on HLA-G in cancer, and address some of the issues concerning its application in human neoplasia.
机译:人白细胞抗原-G(HLA-G)是具有多种免疫调节特性的非经典HLA-Ib类分子。它在生理条件下的主要功能是消除母体针对胎儿的免疫细胞活性,并在母婴界面建立免疫耐受。在肿瘤学中,HLA-G分子在各种人类肿瘤性疾病中异常表达,并且在免疫监控中使肿瘤细胞逃逸起重要作用。在过去的几年中,利用HLA-G蛋白在组织中的表达和体液中的循环水平作为肿瘤标志物已经成为诊断和预后多种人类恶性肿瘤的广泛研究的焦点。另外,基于其免疫耐受功能和针对恶性转化的高度特异性表达,该分子可能成为未来免疫治疗方法的有希望的靶标。在这篇综述中,我们将总结可用的文献数据以及我们自己在癌症中HLA-G的研究成果,并讨论有关其在人类肿瘤形成中的应用的一些问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号